United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 2, 2026

On Jun 1, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$547.87 for US$5.48M under a trading plan, leaving 18,876 shares. Filed Jun 2, 2026 (Form 4).

Sold
10,000 shares
Price
US$547.87 average (US$544.96 to US$554.47)
Value
US$5.48M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockOption exercise10,000US$117.7628,876Direct
Jun 1, 2026Common StockSale1,440US$544.9627,436Direct
Jun 1, 2026Common StockSale2,520US$546.2324,916Direct
Jun 1, 2026Common StockSale1,354US$547.1123,562Direct
Jun 1, 2026Common StockSale1,606US$548.2621,956Direct
Jun 1, 2026Common StockSale1,185US$549.3020,771Direct
Jun 1, 2026Common StockSale1,015US$550.2019,756Direct
Jun 1, 2026Common StockSale200US$550.8119,556Direct
Jun 1, 2026Common StockSale280US$552.9219,276Direct
Jun 1, 2026Common StockSale400US$554.4718,876Direct

Source

View original at SEC

Related